| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |